Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
Clinical trial NCT04446416 · COMPLETED
Trial details
- NCT number
- NCT04446416
- Sponsor
- NaviFUS Corporation
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-21
- Primary completion
- 2022-09-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.